Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected
Novartis
Novartis
Mural Oncology, Inc
AbbVie
University of California, Irvine
Ente Ospedaliero Ospedali Galliera
Aravive, Inc.
Mersana Therapeutics
Pfizer
Morphotek
Tesaro, Inc.
AGO Research GmbH
Endocyte
Pfizer
Amgen
OHSU Knight Cancer Institute
Amgen
Xian-Janssen Pharmaceutical Ltd.
Telik
GOG Foundation
European Organisation for Research and Treatment of Cancer - EORTC
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Unither Pharmaceuticals
InterMune